ラブロフ外相 日本のロシア産原油輸入に反対しない考え示す
ロシアのラブロフ外相は、イラン情勢を背景にした原油価格の高騰に関連して、日本がロシア産の原油の輸入を望む場合は反対しない考えを示し、ウクライナ侵攻を受けたロシアに対する各国からの制裁の解除につなげたい狙いがあるものと見られます。

ロシアのラブロフ外相は、イラン情勢を背景にした原油価格の高騰に関連して、日本がロシア産の原油の輸入を望む場合は反対しない考えを示し、ウクライナ侵攻を受けたロシアに対する各国からの制裁の解除につなげたい狙いがあるものと見られます。
TeknolojiAIGoogle is testing a new opt-out feature in Search Console allowing website owners to control whether their content appears in AI Overviews. This move, prompted by publisher feedback and regulatory pressure from the CMA, aims to give owners more control and negotiation power.
TeknolojiAIDrones are being explored for bear countermeasures, but challenges remain. While drones can detect bears from 80m and their ultrasonic sounds can reach 500m, some urban-habituated bears show no reaction. The Akita Drone Association is collaborating with municipalities on disaster agreements and seeking corporate partnerships for pre-work bear detection.
TeknolojiAIServiceNow and Accenture have launched a "Forward Deployed Engineering" (FDE) program to help companies move from AI agent pilot projects to full-scale enterprise adoption. The program aims to overcome the "wall" between validation and full deployment by having joint FDE teams work within customer environments to build and test AI workflows on the ServiceNow AI Platform.
TeknolojiAI福井県鯖江市のjig.jpが開発したスマートグラス「SABERA」が、応援購入サイト「Makuake」で総額1億円を突破した。生成AIの進化でスマートグラスへの関心が高まる中、日本人のニーズに合わせたデザインと機能が支持されている。
TeknolojiAISAP's Joule AI is transforming retail and supply chains. EssilorLuxottica integrates it with Ray-Ban smart glasses for seamless customer service and inventory management. H&M develops AI agents for in-store operations and customer engagement. Fonterra leverages AI for invoice matching and logistics during its SAP ECC to S/4HANA migration.
TeknolojiAIFRONTEO is focusing on identifying target molecules for drug discovery using its AI engine "KIBIT," which analyzes論文 data to find unknown candidates. This accelerates a process that previously took years to mere days, addressing a key bottleneck in AI-driven drug development.